Hospira Injectable Drug Products: Recall - Visible Particulates from Defective Glass Vials
MedSun: Newsletter #75, August 2012

FDA MedWatch Safety Alert

Hospira and FDA notified healthcare professionals of a nationwide recall of certain injectable drug products, due to visible particles embedded in the glass located at the neck of the vial. There may be potential for product to come into contact with the embedded particles and the particles may become dislodged into the solution. In the event in which particulate matter could be injected into a patient, there may be the potential for patient injury where medical intervention may be required.

Additional Information:

FDA MedWatch Safety Alert. Hospira Injectable Drug Products: Recall - Visible Particulates from Defective Glass Vials. July 16, 2012.
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm312048.htm


MedSun Newsletters are available at www.fda.gov/cdrh/medsun